| Typicality: | 0.265 |
| Saliency: | 0.240 |
| for up to six months | 3 | temporal |
| compared to placebo | 2 | other |
| in sepsis | 2 | location |
| corticosteroid → improve → function | 5 |
| corticosteroid → improve → outcome | 3 |
| negative | neutral | positive |
| 0.106 | 0.294 | 0.600 |
| Raw frequency | 8 |
| Normalized frequency | 0.240 |
| Modifier score | 0.500 |
| Perplexity | 49.765 |